Immunomodulatory Effects of Radiofrequency Ablation in a Breast Cancer Model

By Todorova Valentina K.   Klimberg V. Suzanne   Hennings Leah   Kieber-Emmons Thomas   Pashov Anastas  

Immunological Investigations, Vol. 39, Iss. 1, 2010-01 ,pp. : 74-92

Informa Healthcare

Access to resources Recommend Favorite

Vaccine against breast and ovarian cancer still on the horizon

By Bradbury J.  

Molecular Medicine Today, Vol. 6, Iss. 10, 2000-10 ,pp. : 378-378

Elsevier

Access to resources Recommend Favorite

Non-HLA Gene Polymorphisms and the Outcome of Allogeneic Hematopoietic Stem Cell Transplantation

By  

Current Stem Cell Research & Therapy, Vol. 1, Iss. 2, 2006-05 ,pp. : 239-253

Bentham Science Publishers

Access to resources Recommend Favorite

Taxol-resistance-associated gene-3 (TRAG-3/CSAG2) expression is predictive for clinical outcome in ovarian carcinoma patients

By Materna Verena   Surowiak Paweł   Kaplenko Irina   Spaczyński Marek   Duan Zhenfeng   Zabel Maciej   Dietel Manfred   Lage Hermann  

Virchows Archiv, Vol. 450, Iss. 2, 2007-02 ,pp. : 187-194

Springer Publishing Company

Access to resources Recommend Favorite

Nuclear metallothionein expression correlates with cisplatin resistance of ovarian cancer cells and poor clinical outcome

By Surowiak Paweł   Materna Verena   Maciejczyk Adam   Pudełko Marek   Markwitz Ewa   Spaczyński Marek   Dietel Manfred   Zabel Maciej   Lage Hermann  

Virchows Archiv, Vol. 450, Iss. 3, 2007-03 ,pp. : 279-285

Springer Publishing Company

Access to resources Recommend Favorite